Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,592.40
(
0.20%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
94.34
(
-1.70%
)
Bitcoin
71,137.15
(
-0.32%
)
News Focus
News Focus
Post# of 257682
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123049
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 213510

Sunday, 09/10/2017 4:04:03 PM

Sunday, September 10, 2017 4:04:03 PM

Post# of 257682

Allergan obtained its first FDA approval for Botox in 1989, and has systemically been able to get new uses approved that will keep it the frontrunner forever.

This is an entirely separate issue from AGN’s Restasis ploy. I see nothing improper about AGN’s testing Botox in new indications; to the contrary, as a RVNC long I’m happy to piggyback off of AGN’s new clinical investigations.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today